HKG Equity Snapshot
9887 Weekly Equity Report
Nanjing Leads Biolabs Co., Ltd.
What the company does
Nanjing Leads Biolabs Co., Ltd., a clinical-stage biotechnology company, engages in the research, development, and commercialization of novel antibody drugs worldwide. It develops therapies in oncology, autoimmune, and other severe diseases. The company's lead product LBL-024, a PD-L1/4-1BB bispecific antibody for extra-pulmonary neuroendocrine carcinoma; LBL-007, a novel anti-LAG-3 antibody designed to restore T-cell activity; LBL-034, a novel GPRC5D-targeting T-cell engager for anti-tumor activity. In addition, it develops LeadsBody platform, a portfolio of CD3 T-cell engagers that demonstrate anti-tumor efficacy and safety in preclinical/clinical studies; X-body platform, a 4-1BB/PD-L1 bispecific antibody. The company was founded in …
What the weekly tape is saying
9887 closed the latest completed week at 53.90 HKD. The 4-week return is -15.1% and the 12-week return is -17.1%. Trend Signal is inactive, Market Dynamics is -0.32. Setup signature: Risk-first tape with a 21/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 63.75 HKD
- Vs Trend Line
- -15.4%
- Fair Value
- 64.20 HKD
- Vs Fair Value
- -16.0%
- 52W High
- 97.50 HKD
- 52W Low
- 44.72 HKD
- Drawdown
- -44.7%
- Range Position
- 17.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 9
- 52W Active Breadth
- 19.1%
- Sector Scope
- HK Healthcare
- Sector Rank
- 191 of 257
- Sector Percentile
- 25.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- 64 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 27 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.32
- 4W MD Change
- -145.2%
- Relative Strength
- -
- 4W RS Change
- -
- Expectation
- Undecided
- Probability
- 45.76%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 3.0M
- 13W Average
- 3.9M
- 52W Average
- 4.4M
- Vs 13W
- 0.8x
- Vs 52W
- 0.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 9.8%
- 52W Volatility
- 8.2%
- Upside Weeks
- 19
- Downside Weeks
- 27
- Downside Breadth
- 58.7%
- Avg Gain / Loss
- 7.1% / -5.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 12.1B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 53.90 HKD | -4.6% | 63.75 HKD | 64.20 HKD | -0.32 | - | 3.0M | Off |
| 5 Jun 2026 | 56.50 HKD | -7.8% | 63.92 HKD | 64.42 HKD | -0.20 | - | 2.8M | Off |
| 29 May 2026 | 61.30 HKD | -4.4% | 63.98 HKD | 64.60 HKD | 0.04 | - | 2.7M | On |
| 22 May 2026 | 64.15 HKD | 1.1% | 63.73 HKD | 64.67 HKD | 0.33 | - | 3.2M | On |
| 15 May 2026 | 63.45 HKD | -21.3% | 63.56 HKD | 64.68 HKD | 0.71 | - | 5.2M | On |
| 8 May 2026 | 80.60 HKD | 0.7% | 63.61 HKD | 64.71 HKD | 1.06 | - | 2.0M | On |
| 1 May 2026 | 80.00 HKD | -4.1% | 63.26 HKD | 64.32 HKD | 1.29 | - | 1.6M | On |
| 24 Apr 2026 | 83.40 HKD | -2.9% | 63.01 HKD | 63.93 HKD | 1.51 | - | 4.2M | On |
| 17 Apr 2026 | 85.85 HKD | -6.7% | 62.33 HKD | 63.43 HKD | 1.55 | - | 6.4M | On |
| 10 Apr 2026 | 92.00 HKD | 3.4% | 61.59 HKD | 62.84 HKD | 1.38 | - | 3.7M | On |
| 3 Apr 2026 | 88.95 HKD | 19.4% | 60.72 HKD | 62.06 HKD | 1.25 | - | 8.6M | On |
| 27 Mar 2026 | 74.50 HKD | 14.6% | 59.95 HKD | 61.31 HKD | 0.95 | - | 4.6M | Off |
| 20 Mar 2026 | 65.00 HKD | 4.5% | 59.67 HKD | 60.93 HKD | 0.77 | - | 2.8M | Off |
| 13 Mar 2026 | 62.20 HKD | 15.5% | 59.75 HKD | 60.81 HKD | 0.73 | - | 9.4M | Off |